Abstract To elucidate the effects of codon optimization and chaperone coexpression on the heterologous expression of mammalian cytochrome P450s (P450) in Escherichia coli, the expression of P450s 2B1, 2S1, 2U1, 2W1, and 27C1 were investigated. With codon optimization for N-terminus or the entire gene, the expression levels of P450 27C1, 2U1 and 2W1 increased 22-fold, 3.6-fold and 2.1-fold, respectively, while those for P450s 2B1 and 2S1 remained unchanged. With coexpression of E. coli molecular chaperones GroEL/ES, the expression level increased up to 14-fold for P450 27C1, and 3-to 5-fold for P450s 2B1, 2S1, and 2W1. Simultaneous application of these two techniques resulted in synergetic effects.
Introduction
Cytochrome P450 superfamily is one of the most important groups of oxygenases (Ortiz de Montellano 2005) . They are involved in various biological pathways, and the oxidation of numerous xenobiotics including a large fraction of drugs on the market (Guengerich 2005) . Therefore, a substantial amount of active forms of mammalian cytochrome P450 enzymes are demanded for current drug metabolism and toxicity research. Bacterial expression systems have proven to be a valuable tool for that purpose because of their ease of use, low cost, and high protein production, and are chosen to produce a few commercially available P450s by main manufacturers such as New England Biolabs. Since the successful expression of active bovine P450 17A1 in E. coli by Barnes et al. (1991) , a variety of strategies have been established. However, functional expression in E. coli remains a challenge for some P450s, especially those of mammalian origins, which are all membranebound proteins.
Escherichia coli and mammalian codon preference display considerable divergence (Gustafsson et al. 2004) . Codon bias has been identified as most highly associated with prokaryotic gene expression (Lithwick and Margalit 2003) and a very recent research links it to global translation efficiency and cellular fitness (Kudla et al. 2009 ). In our previous work on human orphan P450s, the utilization of codon optimization technique has been introduced, resulting in the successful heterologous expression of several P450s in E. coli (Wu et al. 2006a, b; Stark et al. 2008a, b) . It is however unclear whether or to what extent this technique contributes to the expression process. We herein present a direct comparison of the expressions of several codon-optimized mammalian P450s with the same enzymes coded with original codons. The effects of coexpression of E. coli molecular chaperone GroEL and its co-chaperone GroES (GroEL/ES), introduced recently to mammalian P450 expressions (Yun et al. 2006) , was also investigated. The chaperone is known to support the de novo protein folding by cycles of binding and release of the substrates after their release from ribosome (Mogk et al. 2002) , therefore facilitates functional heterologous expression. Synergetic effects were observed with both techniques applied.
Materials and methods

Materials
The expression vector of P450s 2S1 with original codons (2S1org), and 2W1 & 27C1 with optimized codons (2W1opt & 27C1opt) were constructed in previous work with N-terminal modification (Wu et al. 2006a, b) . The cDNAs of P450s 2B1 (2B1org) and 2W1 with original codons (2W1org) were gifts from Dr P. F. Hollenberg (Univ. Michigan, Ann Arbor) and Dr M. Ingelman-Sundberg (Karolinska Institute, Stockholm), respectively. Oligonucleotides for cDNA synthesis and N-terminal modifications were purchased from Operon (Huntsville, AL) with salt-free quality and used directly without further purification.
PCR-based cDNA synthesis
The cDNAs of P450s 27C1 with original codons (27C1org) and 2B1 with codon optimized (2B1opt) to suit the codon preference bias of E. coli were synthesized using PCR-based oligonucleotide assembly as described previously (Wu et al. 2006a ). The oligonucleotides were designed online using DNAWorks program (http://helixweb.nih.gov/dnaworks/, Supplementary Tables S1-S3, Figure S1 ) (Hoover and Lubkowski 2002) . Correctly assembled cDNAs were constructed into a pCW vector for expression.
Construction of N-terminal codon-optimized vectors of P450s 2S1 and 2U1 Sequential site-directed mutagenesis was conducted using the QuickChange mutagenesis kit and the supplier's protocol (Stratagene). The primers were designed so that the mutated position was close to the middle with *10-15 bases of template-complementary sequence on both sides (Supplementary Table  S4 ). For practical purpose, a pBluescript SK (?) vector of P450s 2S1 and 2U1 were first constructed and subjected to site-directed mutagenesis (Wu et al. 2005) . The 1.5 kb mutated fragment was subcloned into the pCW vector using the NdeI and XbaI restriction sites. Two and three N-terminal regions ( Fig. 1) with contiguous rare codons were mutated for P450s 2S1 and 2U1 respectively.
N-Terminal modifications for P450s 2B1 and 2W1
N-Terminal mutations were introduced into the native constructs by PCR-based mutagenesis. The cDNAs of P450s 2B1org, 2W1org and 2B1opt were amplified between the NdeI and the XbaI sites using 5 0 -PCR primers containing the desired mutations (Supplementary Table S5 ). PfuUltra High-Fidelity DNA polymerase was used for the PCR amplification at an annealing temperature of 55°C. The products were purified, double-digested, and ligated with the monocistronic pCW vector. The modifications were confirmed by sequencing the ORF region of the new constructs.
Bacterial expression of mammalian P450s
Both plasmids pGro12 ES/EL encoding the chaperone protein GroEL/ES (Nishihara et al. 1998 ) and each of the tested constructs of mammalian P450s were transformed into E. coli DH5a competent cells. Single colonies were grown overnight in LB media fortified with 100 lg ampicillin/ml and 50 lg kanamycin/ml, at 37°C with gyrorotary shaking at 250 rpm; 0.5 ml of each overnight culture was then inoculated into 50 ml of TB broth containing the same antibiotics in a 250 ml flask. The cultures were incubated at 37°C with gyrorotary shaking at 220 rpm for 4 h on an INFORS Multitron shaker; induction of P450s and GroEL/ES transcription were then initiated with the addition of 1 mM IPTG and 1 mg arabinose/ml, respectively. The incubation continued at 27°C with gyrorotary shaking at 200 rpm.
Measurement of P450 concentrations
P450 concentrations were estimated using the reduced-CO versus reduced difference spectrum as described by Omura and Sato (Omura and Sato 1964) . Cells harvested from 1.5 ml culture were resuspended in 3 ml potassium phosphate buffer (0.1 M, pH 7.4) containing 20% (v/v) glycerol and 0.2% (v/v) Emulgen 913. With the sample cuvette saturated with bubbles of CO, spectra from 400-500 nm were recorded until the 450 nm peak reached a maximum. The P450 content is determined as follows: P450 (nmol/l) = [(A 450 -A 490 ) baseline /0.091. Absorbance at 420 nm represents denatured forms of P450.
Results and discussion
This work was undertaken to shed light on the effects of codon optimization and chaperone coexpression on the functional expression of mammalian P450s in E. coli. The expression of mammalian P450s 2B1 (rat), 2S1 (human), 2U1 (human), 2W1 (human), and 27C1 (human) were investigated. In all cases, the N-terminal hydrophobic sequences were truncated or replaced before the well-conserved proline-rich region based on reported examples on successful expressions of P450s. The codon usage of P450s 2B1, 2W1 and 27C1 were optimized by resynthesizing the entire gene. For 2S1 and 2U1, only N-terminalcontiguous rare codons were replaced (Fig. 1) The results are given in Table 1 and typical CO differential spectra of P450 2B1 is shown in Fig. 2 . Both codon optimization and chaperone coexpression showed positive effects on the expression of active P450s in general, albeit to different extents. With codon optimization, the expression of active enzymes increased 22-fold for P450 27C1, 3.6-fold for P450 2U1, and 2.1-fold for P450 2W1, but remained practically unchanged for P450s 2B1 and 2S1. Coexpression of a molecular chaperone GroEL/ES brought the expression level up 14-fold for P450 27C1 and 3-to 5-fold for P450s 2B1, 2S1, and 2W1 (with or without codon optimization).
For P450 2U1, three regions at N-terminus were chosen for the optimization. Constructs with only one region optimized were also tested. Construct with only the first region (PGPTP) optimized (Fig. 1) showed 2-fold increase in active expression level, while those with the second (RRR) or third (RTR) region optimized (Fig. 1) showed 3.6-fold increase. The results revealed that the replacement of Nterminal contiguous rare codons, especially those encoding arginine residues, could be a promising and convenient strategy to improve heterologous expression of mammalian proteins.
When codon adaptation index (CAI) of P450s 2B1, 2W1 and 27C1 were analyzed using OPTI-MIZER (http://genomes.urv.es/optimizer), all optimized sequences had CAIs [0.5, about 0.2 greater than original ones (Supplementary Table S6 ). Their protein yields are as good as or better than those from native genes, although their expression increments varied dramatically as a result of the complicated nature of protein heterologous expression process.
In conclusion, our results demonstrate the general enhancement effect of codon bias adjustment and chaperone coexpression on the bacterial expression of mammalian P450s. They are both easy to perform since both de novo gene synthesis service and some chaperone plasmids are commercially available, and in case of partial codon optimization, sequential sitedirected mutagenesis would be a very straightforward approach. Taken together, the results suggest that these two techniques, plus the use of other available candidate chaperones (Yun et al. 2006) , provide a feasible way to improve functional protein expression, and could be extended to the optimal expression of other mammalian P450s. 
